ACN Newswire

Tue Sep 28

Eisai: Fully Human Anti-TNFalpha Monoclonal Antibody HUMIRA Obtains Additional Approval

Written by ACN Newswire

TOKYO, Sep 27, 2021 - (JCN Newswire) - AbbVie GK, Eisai Co., Ltd., and EA Pharma Co., Ltd announced today the additional approval for a high- dose regimen in adult patients with ulcerative colitis and for a new regimen in pediatric patients regarding fully Human Anti-TNFalpha Monoclonal Antibody HUMIRA (generic name, adalimumab [recombinant];...

ACN Newswire

Eisai: Fully Human Anti-TNFalpha Monoclonal Antibody HUMIRA Obtains Additional Approval

Massacre is now part of Christchurch's identity, so how does a city rise above that?

How not to fall for coronavirus BS: avoid the 7 deadly sins of thought

Grattan on Friday: The price of greasing squeaky wheels ahead of the election

Wayne Swan warns US Democrats not to fall into Labor's trap of overloaded agenda

The Coalition's report card on health includes some passes and quite a few fails

Vital Signs. Might straight down the middle be the source of our economic success?

Curious Kids: where do clouds come from and why do they have different shapes?

They shall not die in vain: how the Islamic State honours its fallen soldiers – and how Australians do the…

Next government must find Australia's place in a turbulent and rapidly changing world

Trust Me, I'm An Expert: Food fraud, the centuries-old problem that won't go away

MYEFO reveals billions more in revenue, $9 billion in fresh election tax cuts